Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.
Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity and prediabetes.
Summit Research and Prime Peptides after an investigation by the FDA found they were selling semaglutide, tirzepatide and/or retatrutide products for human use despite marketing the drugs for ...
The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides ... and weight-loss drug Zepbound use the ingredient tirzepatide. Some of the websites were also offering ...
Summit Research and Prime Peptides, four online companies it said were selling unapproved GLP-1 drugs, including semaglutide and tirzepatide. Semaglutide is known for its use in Wegovy and Ozempic ...
The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides ... and weight-loss drug Zepbound use the ingredient tirzepatide. Some of the websites were also offering ...